This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Referred to as a “selective CB2 agonist ,” such a compound would appear to have potential as a treatment for scleroderma. Two compounds that target the endocannabinoid system are currently in development to treat scleroderma – and they’re already in clinical trials.
Consider it a testament to the ubiquity and flexibility of the endocannabinoid system: we can inhale medicinal cannabinoids via combustion or vaporization; ingest them via food or drink; and absorb them directly through the skin, the bodys largest organ. This latter category is broader and more complex than many of us give it credit for.
A 2006 edition of Current Pharmacology published an article titled: “Role of the Cannabinoid System in Pain Control and Therapeutic Implications for the Management of Acute and Chronic Pain Episodes”. Cannabinoid Receptors , referred to as CB1 and CB2, are an essential part of the human body’s endocannabinoid system.
Treatment usually aims at reducing reactions and to diminishing the acuity of the reactions. Treatments also seek to increase the subject’s ability to manage trauma-related emotions and to greater confidence in coping abilities. The endocannabinoid system consists of cannabinoid receptors all over the body.
Of the people who take antidepressants, 30% won’t respond to treatment. But what other options do people suffering from depression, particularly treatment-resistant depression, have? What is ketamine treatment? Ketamine treatment for depression may be one of the biggest leaps forward in mental healthcare in decades.
Ten years ago, most cannabis consumers couldn’t tell a terpene from a cannabinoid. A 2021 study 2 by University of Arizona scientists concluded that certain terpenes are “cannabimimetic” (in a mouse model of cannabis intoxication) and can selectively enhance cannabinoid activity. But today things are different.
Interestingly, a peer-reviewed study published in Lancet Psychiatry found that a particular cannabinoid in marijuana – cannabidiol (CBD) – effectively treated “moderate” to “severe” cases of cannabis use disorder. Cannabidiol could offer a novel treatment, [and] could help people to quit in an acceptable treatment format.
Project CBD recently reported on studies indicating that cannabis terpenes — the compounds that give the plant its robust and distinctive smell — activate the CB1 cannabinoid receptor. What’s more, in the presence of THC (also a CB1 agonist), terpenes appear to modulate cannabinoid activity in varied and interesting ways.
While traditional treatments like antiepileptic drugs exist, they may not always provide adequate relief for all patients. In recent years, there has been growing interest in exploring alternative treatment options, and one that has gained attention is medical marijuana (MMJ).
Historical sources show that people as early as 300 BCE were aware of cannabis’ appetite-stimulating effects —particularly for sweet and savory food—but who’d have thought that worms (that’s right, worms) also get a case of “the munchies” after being exposed to cannabinoids?
In this blog post, we will explain everything you need to know about the top cannabinoids in cannabis and how they work together with other cannabis compounds to produce an ideal effect on your body. Learning more about other cannabinoids can help you select a cannabis strain that better meets your needs. What Is a Cannabinoid?
In recent years, the landscape of cancer treatment has witnessed a paradigm shift with the emergence of medical cannabis as a potential therapeutic ally. Today we’re here to explore the evolving relationship between medical cannabis and cancer treatment, shedding light on everything potential MMJ patients need to know.
THCjd, also known as Tetrahydrocannabinol jd, is a cannabinoid that has gained attention in recent years. THCjd is a recent cannabinoid discovery as of 2020. THCjd is a cannabinoid that has distinct properties and potential therapeutic benefits. However, THCjd is touted as a non-intoxicating cannabinoid.
Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. However, because cannabinoids reduce seizures through numerous mechanisms of actions, possible drug interactions are still unclear.
The cannabis plant is one of the oldest medicinal plants known to humans, with historical references dating back 5 to 10 thousand years. In “ The Cannabis and Cannabinoids: Pharmacology, Toxicology, and Therapeutic Potential” written by Franjo Grotenhermen and Ethan Russo, the authors cite the 1964 discovery of THC by Gaoni and Mechoulam.
For those who may not know, the number of cannabinoids we know about are few in comparison to the compounds on the cannabis plant. Simply put, Delta-10 THC is one of the hundreds of types of cannabinoids that can be found on the plant. Taking the edge off does not refer to getting high, but rather to noticeably becoming more relaxed.
When unpleasant symptoms occur due to consuming large quantities of THC, it is referred to as Acute Cannabinoid Intoxication (ACI), and it can lead to people seeking emergency medical treatment. Now, a […].
Marijuana as a treatment for epilepsy. Medical cannabis is showing great potential in the treatment of epilepsy. CONVENTIONAL TREATMENT. One of the goals of treating epilepsy is to allow people to continue to live functional and fulfilling life’s epilepsy treatment. CANNABIS AS A POTENTIAL TREATMENT.
Hence, lupus patients often look for complementary treatments for controlling their symptoms. Fortunately enough, a large body of evidence shows that cannabis may prove to be a good treatment option for lupus. Is Cannabis a Good Treatment Option for Eating Disorders? Here’s what I found. What is lupus?
More than ever, cannabis can aid in the treatment of chronic disease and as a supplement to other medical interventions and treatments. The endocannabinoid system consists of cannabinoid receptors all over the body. For centuries, humans have relied on the cannabis plant for its therapeutic properties. Appetite Stimulant.
It was once a common assumption within the cannabis community that plant cannabinoids aren’t “activated” or useful until they are “decarbed” — short for decarboxylated — which refers to the process of heating cannabis before it is consumed. But that notion has proven to be way off the mark. Cannabis roots.
Traditional treatments, while helpful to some extent, often come with limitations and side effects that can further burden individuals already dealing with a debilitating disease. Medical marijuana has emerged as a promising alternative treatment option for managing symptoms associated with MS.
British firm GW Pharmaceuticals is licking its wounds after US judges tossed out its attempt to patent multiple cannabinoids for epilepsy treatment following an eight-year battle. The patent, which has been embroiled in dispute since 2010, is for “the use of one or more cannabinoids in the treatment of epilepsy”.
The majority of people who use the cannabinoid cannabigerol (CBG) for medical reasons find it to be helpful or very helpful in treating a variety of health conditions, according to the findings of a recent survey. Why is CBG ‘the mother of all cannabinoids?’.
Now, a new study has found that medical marijuana (MMJ) shows promise as a treatment for MS. . As with many other conditions, there is a lack of research regarding the use of MMJ as an alternative treatment to relieve symptoms of MS. . The Need for Better MS Treatment. The Need for Better MS Treatment.
On 14 November 2019, the Senate referred an inquiry into the current barriers to patient access to medicinal cannabis in Australia to the Senate Community Affairs References Committee for inquiry and report by 12 February 2020. Further detail about the scope of the inquiry is provided in the terms of reference. Track Inquiry.
The effects of cannabis are caused by cannabinoids, which are chemical compounds found in the resin glands on the leaves and buds of female marijuana plants. Cannabinoids can help with inflammation and pain relief in various ways. Cannabis contains two types of cannabinoids: phytocannabinoids and endocannabinoids.
I wanted to find out if there is some evidence of successful application of cannabis for eating disorders, so I decided to start off with figuring out what eating disorders actually are and which studies explain the complex relationship between eating and cannabinoids. What are eating disorders?
cannabis has been used medicinally as a treatment for pain and other ailments. Today, you can explore personalized treatment plans to aid your distinctive needs. Patients with these conditions frequently seek relief from a variety of traditional treatments. Medicine and orthopedic concept. Since 2727 B.C.
Understanding Cannabinoids: The Basics of CBD and THC Cannabinoids, CBD, THC—chances are you’ve heard these terms buzzing around lately, and for good reason! Cannabinoids are typically extracted from cannabis plants through a variety of methods. Once extracted, these cannabinoids interact with your body’s endocannabinoid system.
Traditional treatments include eye drops, oral medications, laser treatment, and surgery. This article explores the potential of medical marijuana for glaucoma treatment, focusing on its benefits, risks, and legal considerations. Several studies have shown that cannabinoids, the active compounds in marijuana, can lower IOP.
The condition, known as “long COVID” — with patients often referred to as “COVID long haulers” — is typified by a series of symptoms that linger long after someone has recovered from COVID-19, even months after they no longer test positive for the novel coronavirus. What are the symptoms of long COVID? episodes per month. episodes per month.
Neil Mahapatra is a co-founder of the Oxford Cannabinoid Technologies (OCT) which floated on the LSE in the May this year, he is also founder of UK venture capital business Kingsley Capital Partners (KCP). Oxford Cannabinoid Technologies’ Shares Fall A Further 20% As Chairman Stands Down Following Market Rule Breach.
Medical Marijuana’s Impact on ALS Symptoms Amyotrophic lateral sclerosis (ALS), often referred to as Lou Gehrig’s disease, is a devastating neurodegenerative disorder that affects nerve cells in the brain and spinal cord. It makes your muscles weaker over time, and eventually, you can’t move or breathe like you used to.
These terms refer to the chemical composition of cannabis plants, which is one of the main factors that determine the type of high you’ll experience, or the effectiveness of your cannabis treatment. Chemotypes : Types of cannabis that are grouped by their most abundant cannabinoid. For example, Type 1 cannabis is THC dominant.
With medical and adult-use dispensaries in dozens of US states, and an ever-growing cornucopia of CBD products available, both of these uber-famous cannabinoids are approaching household name status. The same cannot be said for cannabigerol (CBG) — but that may be changing. What is CBG? How CBG works. How to use CBG.
Often simply referred to as caryophyllene, this naturally occurring terpene is not just present in cannabis — it is quite common among plants, including many fruits, vegetables, herbs, and spices. Beta-caryophyllene (b-caryophyllene or BCP) is one of the most abundant terpenes found in cannabis. What does b-caryophyllene do?
These are just a sampling of the close to 100 known cannabinoids found in marijuana. The properties and effects of major cannabinoids such as THC and CBD are generally well known within the medical marijuana community, but they are far from the only components of the cannabis plant that hold potential health and therapeutic benefits.
As more and more states legalize cannabis use, the demand for medical cannabis products and cannabinoid-based therapies continues to grow. Unfortunately, almost half of the group (40–50% depending on subject) felt unfamiliar with cannabinoid pharmacology and clinical applications. A total of 43% favored legal recreational cannabis.
While these traditional distinctions are still useful as a starting reference, the growing consensus among experts is that analyzing a marijuana strain’s profile, including its cannabinoid and terpenoid content , can provide a more accurate assessment of its therapeutic potential.
Medical cannabis has been legal in the nation for almost three years—so why are MS patients struggling to access the treatment? Though a cure for MS does not yet exist, cannabinoids have been found to help relieve patients’ body pain and improve their overall quality of life. Multiple Sclerosis: A Quick Overview. More on Sativex.
Prevailing thought associates Cannabinoids with the Cannabis plant. However, the human body contains many cannabinoid receptors that are regularly activated by cannabinoids that are found in everyday common products and foods. The ECS is the network of cannabinoid receptors already present in humans and animals.
Medical marijuana is a potential treatment for insomnia, and it offers an alternative to traditional pharmaceuticals. Chronic insomnia often requires a more comprehensive treatment approach. It consists of cannabinoid receptors, endocannabinoids produced by the body, and enzymes that regulate their synthesis and degradation.
One of the main reasons people use CBD oil is because it interacts with receptors throughout our bodies called cannabinoid receptors (CB1 and CB2). Helping reduce anxiety or stress levels that come along with managing this chronic disease (which is often referred to as “diabetes distress”).
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content